Measurement of in vivo mutations in human lymphocytes.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 6828165)

Published in Nature on March 10, 1983

Authors

A A Morley, K J Trainor, R Seshadri, R G Ryall

Articles citing this

RglB facilitated cloning of highly methylated eukaryotic DNA: the human L1 transposon, plant DNA, and DNA methylated in vitro with human DNA methyltransferase. Nucleic Acids Res (1988) 1.71

Detection of single base changes in nucleic acids. Biochem J (1989) 1.05

Mutations in human lymphocytes commonly involve gene duplication and resemble those seen in cancer cels. Proc Natl Acad Sci U S A (1988) 1.01

Mutational spectrum at the Hprt locus in splenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea. Proc Natl Acad Sci U S A (1992) 1.00

A review of approaches to the detection of genetic damage in the human fetus. Environ Health Perspect (1987) 0.90

Fine structure mapping of the hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene region of the human X chromosome (Xq26). Am J Hum Genet (1991) 0.89

Interindividual variation in mitotic recombination. Am J Hum Genet (1999) 0.89

Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus. J Exp Med (1992) 0.88

Molecular characterization of 15 rearrangements among 90 human in vivo somatic mutants shows that deletions predominate. Mol Cell Biol (1987) 0.87

Spontaneous loss and alteration of antigen receptor expression in mature CD4+ T cells. J Exp Med (1990) 0.87

Human somatic mutation assays as biomarkers of carcinogenesis. Environ Health Perspect (1991) 0.86

Diagnosis of heterozygous states for adenine phosphoribosyltransferase deficiency based on detection of in vivo somatic mutants in blood T cells: application to screening of heterozygotes. Am J Hum Genet (1991) 0.82

Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. J Clin Invest (1994) 0.81

Cloning of phenotypically different human lymphocytes originating from a single stem cell. J Exp Med (1989) 0.81

Spontaneously arising red cells with a McLeod-like phenotype in normal donors. Mutat Res (2009) 0.81

In vivo mutations in human blood cells: biomarkers for molecular epidemiology. Environ Health Perspect (1993) 0.80

The rate of spontaneous mutations in human myeloid cells. Mutat Res (2013) 0.79

Mutations induced in the hypoxanthine phosphoribosyl transferase gene by three urban air pollutants: acetaldehyde, benzo[a]pyrene diolepoxide, and ethylene oxide. Environ Health Perspect (1994) 0.78

Mutation rates at the glycophorin A and HPRT loci in uranium miners exposed to radon progeny. Occup Environ Med (1996) 0.78

Monitoring exposure to atomic bomb radiation by somatic mutation. Environ Health Perspect (1996) 0.77

Rapid fluorometric detection of drug resistant tumour cells. Br J Cancer (1985) 0.77

Modulation of antifolate cytotoxicity by metabolites from dying cells in a lymphocyte clonal assay. Br J Cancer (1988) 0.77

Ligation of high-melting-temperature 'clamp' sequence extends the scanning range of rare point-mutational analysis by constant denaturant capillary electrophoresis (CDCE) to most of the human genome. Nucleic Acids Res (2003) 0.76

Leukemic blasts with the paroxysmal nocturnal hemoglobinuria phenotype in children with acute lymphoblastic leukemia. Am J Pathol (2012) 0.76

Somatic cell gene mutations in humans: biomarkers for genotoxicity. Environ Health Perspect (1993) 0.76

Characterization of in vivo somatic mutations at the hypoxanthine phosphoribosyltransferase gene of a human control population. Environ Health Perspect (1993) 0.75

Articles by these authors

Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science (2003) 8.79

Quantitation of targets for PCR by use of limiting dilution. Biotechniques (1992) 4.65

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol (2000) 3.56

Measurement of micronuclei in lymphocytes. Mutat Res (1985) 3.26

Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood (1991) 2.80

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet (1994) 2.62

Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr (2001) 2.54

Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol (1990) 2.36

Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood (1990) 2.32

Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol (1990) 1.89

In vivo somatic mutations in human lymphocytes frequently result from major gene alterations. Nature (1985) 1.80

Effect of total leucocyte count on whole blood filterability in patients with peripheral vascular disease. J Clin Pathol (1981) 1.78

Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. BMJ (1991) 1.68

Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low dose X-irradiation. Mutat Res (1986) 1.64

A neutrophil cycle in healthy individuals. Lancet (1966) 1.43

In vivo human somatic mutation: frequency and spectrum with age. Mutat Res (1992) 1.42

Mutation rate of normal and malignant human lymphocytes. Cancer Res (1987) 1.42

HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years. J Natl Cancer Inst (1999) 1.40

Lp(a) and insulin dose in IDDM. Diabetes Care (1993) 1.39

Adrenal steroids and haemolysis in paroxysmal nocturnal haemoglobinuria. Lancet (1967) 1.39

Effect of the Philadelphia chromosome on minimal residual disease in acute lymphoblastic leukemia. Leukemia (1997) 1.38

Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience. BMJ (1994) 1.35

Accuracy of bedside clinical methods compared with fiberoptic endoscopic examination of swallowing (FEES) in determining the risk of aspiration in acute stroke patients. Dysphagia (2001) 1.33

DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Cancer Res (1989) 1.31

A simple index using video image analysis to predict disease outcome in primary breast cancer. Int J Cancer (1999) 1.31

Complete and draft genome sequences of six members of the Aquificales. J Bacteriol (2009) 1.27

Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res (2001) 1.23

Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity. Int J Cancer (1974) 1.23

Diagnostic use of immunoglobulin and T-cell receptor gene rearrangements in lymphoproliferative disease. Aust N Z J Med (1987) 1.22

Rapid method for detecting monoclonality in B cell lymphoma in lymph node aspirates using the polymerase chain reaction. J Clin Pathol (1992) 1.21

Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia. Leukemia (1995) 1.15

RCH-ACV: a lymphoblastic leukemia cell line with chromosome translocation 1;19 and trisomy 8. Cancer Genet Cytogenet (1986) 1.10

Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells. Cancer Res (2000) 1.08

Effective use of blood in elective surgical procedures. Med J Aust (1979) 1.08

EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene (1997) 1.08

Human lymphocytes aged in vivo have reduced levels of methylation in transcriptionally active and inactive DNA. Mutat Res (1989) 1.07

Mutation frequency in human lymphocytes increases with age. Mech Ageing Dev (1984) 1.05

Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer. Int J Cancer (1995) 1.04

Familial cyclical neutropenia. Br J Haematol (1967) 1.04

High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol (2000) 1.02

Large DNA fragment sizing using native acrylamide gels on an automated DNA sequencer and GENESCAN software. Biotechniques (1998) 1.01

The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia. BJOG (2000) 1.01

Early resistance to therapy during induction in childhood acute lymphoblastic leukemia. Cancer Res (2000) 1.01

Mutations in human lymphocytes commonly involve gene duplication and resemble those seen in cancer cels. Proc Natl Acad Sci U S A (1988) 1.01

Delayed DNA methylation is an integral feature of DNA replication in mammalian cells. Exp Cell Res (1986) 0.98

The effect of donor age on spontaneous and induced micronuclei. Mutat Res (1985) 0.97

Effect of dietary restriction on in vivo somatic mutation in mice. Mutat Res (1993) 0.97

Outcome of polyester cuff retention following traction removal of tunneled central venous catheters. Radiology (2001) 0.97

Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Clin Cancer Res (2000) 0.97

Isolation of fetal trophoblast cells from peripheral blood of pregnant women. Lancet (1990) 0.96

Effect of alcohol on haemopoiesis. Br Med J (1966) 0.96

Cloning of human lymphocytes using limiting dilution. Exp Hematol (1983) 0.96

The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia. Leukemia (1994) 0.96

Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer. Genomics (1998) 0.95

Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia. Br J Haematol (1997) 0.95

Kinetochore detection in micronuclei: an alternative method for measuring chromosome loss. Mutagenesis (1989) 0.94

Lack of an effect of vitamin E on lifespan of mice. Biogerontology (2001) 0.93

Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer. Clin Cancer Res (1998) 0.93

Exposure of human lymphocytes to ionizing radiation reduces mutagenesis by subsequent ionizing radiation. Mutat Res (1986) 0.93

Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain gene. Blood (1993) 0.93

Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reaction. Br J Haematol (1991) 0.91

The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer. Genomics (1999) 0.90

Mutations in human lymphocytes studied by an HLA selection system. Mutat Res (1988) 0.90

Fine needle aspiration cytology in the management of lymphoma. Aust N Z J Med (1983) 0.89

Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. Hum Genet (1987) 0.89

Induction of somatic intrachromosomal recombination inversion events by cyclophosphamide in a transgenic mouse model. Mutat Res (1998) 0.88

Cyclic leucocytosis as evidence for retention of normal homoeostatic control in chronic granulocytic leukaemia. Lancet (1967) 0.88

Human somatic mutation at the autosomal HLA-A locus. Prog Clin Biol Res (1990) 0.88

Methods for study of mutations and mutagenesis in human lymphocytes. Mutat Res (1985) 0.88

The impact of swallowing disorders in the elderly. Ann Acad Med Singapore (2001) 0.88

Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer. Genomics (1998) 0.88

Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighbours. Eur J Cancer (1993) 0.87

Measurement of in vivo mutant frequency in lymphocytes in the mouse. Environ Mutagen (1986) 0.87

Increased mutation frequency following treatment with cancer chemotherapy. Cancer Res (1985) 0.87

Immunologic abnormalities in an animal model of chronic hypoplastic marrow failure induced by busulfan. Blood (1978) 0.87

Seasonal variation in the presentation of abdominal pain. J Pediatr Gastroenterol Nutr (2008) 0.87

Validity of transcobalamin II-based radioassay for the determination of serum vitamin B12 concentrations. Ann Clin Biochem (1980) 0.87

Underutilization of breast-conserving therapy in a predominantly rural population: need for improved surgeon and public education. Clin Breast Cancer (2000) 0.86

Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests. Br J Haematol (1996) 0.86

Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells. Biochem Biophys Res Commun (1985) 0.86

Molecular basis of X-ray-induced mutation at the HPRT locus in human lymphocytes. Mutat Res (1986) 0.86

Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction. Blood (1988) 0.86

Routine measurement of glycosylated haemoglobin. Lancet (1978) 0.86

Why generic and disease-specific quality-of-life instruments should be used together for the evaluation of patients with persistent allergic rhinitis. Clin Exp Allergy (2005) 0.86

Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site. Mol Pharmacol (1992) 0.85

Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood (1996) 0.85

Long-term administration of desferrioxamine in thalassaemia major. Arch Dis Child (1974) 0.85

Glycosylated haemoglobin and relative polycythaemia in diabetes mellitus. Diabetologia (1980) 0.84

Reduced lymphocyte colony formation with age. Clin Exp Immunol (1982) 0.84